The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Kinetics of the inhibition of thrombin by hirudin
Abstract
The dissociation constant for hirudin was determined by varying the concentration of hirudin in the presence of a fixed concentration of thrombin and tripeptidyl p-nitroanilide substrate. The estimate of the dissociation constant determined in this manner displayed a dependence on the concentration of substrate which suggested the existence of two binding sites at which the substrate was able to compete with hirudin. A high-affinity site could be correlated with the binding of the substrate at the active site, and the other site had an affinity for the substrate that was 2 orders of magnitude lower. Extrapolation to zero substrate concentration yielded a value of 20 fM for the dissociation constant of hirudin at an ionic strength of 0.125. The dissociation constant for hirudin was markedly dependent on the ionic strength of the assay; it increased 20-fold when the ionic strength was increased from 0.1 to 0.4. This increase in dissociation constant was accompanied by a decrease in the rate with which hirudin associated with thrombin. This rate could be measured with a conventional recording spectrophotometer at higher ionic strength and was found to be independent of the binding of substrate at the active site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors
Morrison, J. F. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90420-3 · Cited by 814
[17] The kinetics of reversible tight-binding inhibition
Williams, J. W., & Morrison, J. F. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63019-7 · Cited by 693
[23] Buffers of constant ionic strength for studying pH-dependent processes
Ellis, K. J., & Morrison, J. F. (1982) · Methods in Enzymology · doi:10.1016/s0076-6879(82)87025-0 · Cited by 646
A nonlinear regression program for small computers
Duggleby, R. G. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90104-4 · Cited by 562
Henderson, P. J. F. (1972) · Biochemical Journal · doi:10.1042/bj1270321 · Cited by 522
The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions
Morrison, J. F. (1982) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(82)90157-8 · Cited by 496
Jameson, G. W., Roberts, D. V., Adams, R. W., Kyle, W. S. A., & Elmore, D. T. (1973) · Biochemical Journal · doi:10.1042/bj1310107 · Cited by 375
Hunkapiller, M. W., & Hood, L. E. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)91045-5 · Cited by 359
A simple test for inactivation of an enzyme during assay
Selwyn, M. J. (1965) · Biochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation · doi:10.1016/s0926-6593(65)80190-4 · Cited by 253
Cited by
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181940 · Cited by 1,853
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.013 · Cited by 1,510
Intrinsically Disordered Proteins in Human Diseases: Introducing the D2Concept
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,410
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Natural protein proteinase inhibitors and their interaction with proteinases
BODE, W., & HUBER, R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16654.x · Cited by 1,043
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00889-5 · Cited by 963
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.014 · Cited by 960
The Behavior and Significance of Slow‐Binding Enzyme Inhibitors
Morrison, J. F., & Walsh, C. T. (1988) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123072.ch5 · Cited by 840
Peptidomimetics—Tailored Enzyme Inhibitors
Gante, J. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199416991 · Cited by 825
The Structure of a Complex of Recombinant Hirudin and Human α-Thrombin
Rydel, T. J., Ravichandran, K. G., Tulinsky, A., Bode, W., Huber, R., Roitsch, C., & Fenton, J. W. (1990) · Science · doi:10.1126/science.2374926 · Cited by 709
Bode, W., Turk, D., & Karshikov, A. (1992) · Protein Science · doi:10.1002/pro.5560010402 · Cited by 627
Wright, R. S., Anderson, J. L., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Jneid, H., Lincoff, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.011 · Cited by 516
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W. (1990) · Biochemistry · doi:10.1021/bi00482a021 · Cited by 466
A player of many parts: The spotlight falls on thrombin's structure
Stubbs, M. T., & Bode, W. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90002-6 · Cited by 441
The mechanism of inactivation of human factor V and human factor Va by activated protein C.
Kalafatis, M., Rand, M. D., & Mann, K. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31776-9 · Cited by 405
Refined structure of the Hirudin-thrombin complex
Rydel, T. J., Tulinsky, A., Bode, W., & Huber, R. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80074-5 · Cited by 368
The Biology and Enzymology of Protein Tyrosine O-Sulfation
Moore, K. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300008200 · Cited by 360
Meloche, S. (1992) · Molecular Endocrinology · doi:10.1210/me.6.5.845 · Cited by 290
Blood compatible materials: state of the art
Liu, X., Yuan, L., Li, D., Tang, Z., Wang, Y., Chen, G., Chen, H., & Brash, J. L. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00881b · Cited by 288
2007 WRITING COMMITTEE MEMBERS, Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828478ac · Cited by 272
Post-translational modifications of protein biopharmaceuticals
Walsh, G. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.009 · Cited by 263
Cannon, C. P., McCabe, C. H., Henry, T. D., Schweiger, M. J., Gibson, R. S., Mueller, H. S., Becker, R. C., Kleiman, N. S., Haugland, J. M., Anderson, J. L., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90581-9 · Cited by 257
Di Cera, E. (2020) · Biophysics Reviews · doi:10.1063/5.0020997 · Cited by 73
Metadata
- Authors
- Stone, S. R., & Hofsteenge, J.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1986-08-01
- Volume
- 25
- Issue
- 16
- Pages
- 4622-4628
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2013547341
- Cited by
- 586
- References
- 15
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.